| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 21 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-10-21 |
4 |
B |
$15.60 |
$4,680 |
I/I |
300 |
10,824,073 |
2.17 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-10-22 |
4 |
B |
$15.86 |
$29,500 |
I/I |
1,860 |
10,825,933 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-11-03 |
4 |
B |
$17.00 |
$25,500 |
I/I |
1,500 |
10,827,433 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-27 |
4 |
S |
$2.05 |
$205 |
I/I |
(100) |
10,840,417 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-26 |
4 |
S |
$2.05 |
$26,209 |
I/I |
(12,763) |
10,840,517 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-25 |
4 |
S |
$2.06 |
$26,363 |
I/I |
(12,818) |
10,853,280 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-22 |
4 |
S |
$2.09 |
$151,592 |
I/I |
(72,591) |
10,866,098 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-11-04 |
4 |
B |
$16.80 |
$862,462 |
I/I |
51,337 |
10,878,770 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-11-05 |
4 |
B |
$16.81 |
$200,022 |
I/I |
11,899 |
10,890,669 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-21 |
4 |
S |
$2.10 |
$32,642 |
I/I |
(15,566) |
10,938,689 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-20 |
4 |
S |
$2.10 |
$42,484 |
I/I |
(20,277) |
10,954,255 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-19 |
4 |
S |
$2.05 |
$61,078 |
I/I |
(29,723) |
10,974,532 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-04 |
4 |
S |
$1.99 |
$203,153 |
I/I |
(102,000) |
11,004,255 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2020-12-31 |
4 |
S |
$1.90 |
$189,207 |
I/I |
(99,382) |
11,106,255 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2020-12-30 |
4 |
S |
$1.95 |
$65,783 |
I/I |
(33,697) |
11,205,637 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-08-25 |
4 |
B |
$18.20 |
$45,500 |
I/I |
2,500 |
11,231,179 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-12-15 |
4 |
B |
$17.00 |
$39,999,997 |
I/I |
2,352,941 |
11,238,178 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2020-12-08 |
4 |
S |
$1.85 |
$118,185 |
I/I |
(63,746) |
11,239,334 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-01-21 |
4 |
B |
$15.02 |
$150,200 |
I/I |
10,000 |
11,248,178 |
2.25 |
- |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2022-04-07 |
4 |
B |
$1.79 |
$5,000,000 |
I/I |
2,793,296 |
11,256,460 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-02-02 |
4 |
B |
$13.46 |
$269,200 |
I/I |
20,000 |
11,268,178 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2020-12-07 |
4 |
S |
$1.91 |
$125,367 |
I/I |
(65,782) |
11,303,080 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-02-03 |
4 |
B |
$13.09 |
$655,809 |
I/I |
50,100 |
11,318,278 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-02-04 |
4 |
B |
$12.98 |
$129,800 |
I/I |
10,000 |
11,328,278 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-02-05 |
4 |
B |
$12.65 |
$92,446 |
I/I |
7,308 |
11,335,586 |
2.25 |
- |
|
634 Records found
|
|
Page 21 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
